Evidence map›Paper›PMID 24658508›Full record

ArticleThe Journal of investigative dermatology2014

Hyaluronan metabolism in human keratinocytes and atopic dermatitis skin is driven by a balance of hyaluronan synthases 1 and 3.

Jérémy Malaisse, Virginie Bourguignon, Evelyne De Vuyst, Catherine Lambert de Rouvroit, Arjen F Nikkels, Bruno Flamion, Yves Poumay

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Ameliorative effects ofMolecular medicine reports · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Role of MicroRNA in the Pathogenesis of Atopic Dermatitis.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Advances in pharmacological and pharmaceutical sciences · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jérémy MalaisseResearch Unit of Molecular Physiology (URPHYM), NARILIS, University of Namur, Namur, Belgium.
Virginie BourguignonResearch Unit of Molecular Physiology (URPHYM), NARILIS, University of Namur, Namur, Belgium.
Evelyne De VuystResearch Unit of Molecular Physiology (URPHYM), NARILIS, University of Namur, Namur, Belgium.
Catherine Lambert de RouvroitResearch Unit of Molecular Physiology (URPHYM), NARILIS, University of Namur, Namur, Belgium.
Arjen F NikkelsDepartment of Dermatology, University Medical Center of Liège, Liège, Belgium.
Bruno FlamionResearch Unit of Molecular Physiology (URPHYM), NARILIS, University of Namur, Namur, Belgium.
Yves PoumayResearch Unit of Molecular Physiology (URPHYM), NARILIS, University of Namur, Namur, Belgium. Electronic address: yves.poumay@unamur.be.
University of Namur · BEUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyaluronan (HA) is a glycosaminoglycan synthesized directly into the extracellular matrix by three hyaluronan synthases (HAS1, HAS2, and HAS3). HA is abundantly synthesized by keratinocytes but its epidermal functions remain unclear. We used culture models to grow human keratinocytes as autocrine monolayers or as reconstructed human epidermis (RHE) to assess HA synthesis and HAS expression levels during the course of keratinocyte differentiation. In both the models, epidermal differentiation downregulates HAS3 mRNA expression while increasing HAS1 without significant changes in hyaluronidase expression. HA production correlates with HAS1 mRNA expression level during normal differentiation. To investigate the regulation of HAS gene expression during inflammatory conditions linked to perturbed differentiation, lesional and non-lesional skin biopsies of atopic dermatitis (AD) patients were analyzed. HAS3 mRNA expression level increases in AD lesions compared with healthy and non-lesional skin. Simultaneously, HAS1 expression decreases. Heparin-binding EGF-like growth factor (HB-EGF) is upregulated in AD epidermis. An AD-like HAS expression pattern is observed in RHE incubated with HB-EGF. These results indicate that HAS1 is the main enzyme responsible for HA production by normal keratinocytes and thus, must be considered as an actor of normal keratinocyte differentiation. In contrast, HAS3 can be induced by HB-EGF and seems mainly involved in AD epidermis.

Indexed as

Cells, CulturedDermatitis, AtopicErbB ReceptorsGlucuronosyltransferaseHumansHyaluronan SynthasesHyaluronic AcidKeratinocytesSkinErbB ReceptorsGlucuronosyltransferaseHAS1 protein, humanHAS3 protein, humanHyaluronan SynthasesHyaluronic Acid

Identifiers

PMID24658508
OpenAlexW2005637791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.